HEMGENIX

Serial Number 97037223
Registration 7045999
700

Registration Progress

Application Filed
Sep 21, 2021
Under Examination
Approved for Publication
Feb 21, 2023
Published for Opposition
Feb 21, 2023
Registered
May 9, 2023

Trademark Image

HEMGENIX

Basic Information

Serial Number
97037223
Registration Number
7045999
Filing Date
September 21, 2021
Registration Date
May 9, 2023
Published for Opposition
February 21, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
May 9, 2023
Registration
Registered
Classes
005

Rights Holder

CSL Behring L.L.C.

16
Address
1020 First Avenue
King of Prussia, PA 19406

Ownership History

CSL Behring L.L.C.

Original Applicant
16
King of Prussia, PA

CSL Behring L.L.C.

Owner at Publication
16
King of Prussia, PA

CSL Behring L.L.C.

Original Registrant
16
King of Prussia, PA

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

Next Deadline
1193 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230509)
Due Date
May 09, 2029
Grace Period Ends
November 09, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
May 9, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 9, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 21, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 21, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 1, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 18, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 6, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 6, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 6, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Dec 30, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Dec 30, 2022 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Dec 30, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Dec 27, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 27, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 27, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 27, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 27, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 27, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 22, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 26, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 24, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 24, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in gene therapy and cell therapy for the treatment of hemophilia

Additional Information

Design Mark
The mark consists of "HEMGENIX", where the "X" contains a helix design.

Classification

International Classes
005